Where does Grail, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Grail, Inc. ranks #6,152 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Grail, Inc. hold?

Grail, Inc. holds 55 US utility patents granted between 2018 and 2025, spanning 12 technology areas.

What is Grail, Inc.'s Innovation Score?

Grail, Inc. has an Innovation Score of 59.7 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Grail, Inc.'s patent grant rate increasing or decreasing?

Grail, Inc.'s recent grant velocity is +2100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Grail, Inc.'s patents?

Grail, Inc.'s patents average 22.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Grail, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Grail, Inc.

Q: What technology areas does Grail, Inc. focus on?

Grail, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 45 patents, ranking #106 of 2,502 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 55 granted patents across 12 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Grail ranks #6,152 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 12 technology areas.

#6,152
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.7/100): 22.6
avg claims per patent: +2100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6152 · US Corporation #6,152 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,152/49,997
PHOTO-FINISH Florida A&M University
CPC-FOCUS C12Q · 12 areas
INNOV-PAR 59.7/100
CLAIMS-DENSE 22.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +2100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Florida A&M University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Grail’s 59.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (23%) Velocity 20.0 pts (34%) Breadth 12.2 pts (20%) Claim depth 13.5 pts (23%)

Qualcomm Incorporated · highest

85
Beijing Xiaomi… · near

60
Gojo Industries · near

60
Grail · this assignee

60
Lexmark International · near

60
NCR Atleos · near

60
3D Lighting… · lowest

7

What this shows Grail's Innovation Score is 59.7/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Grail?

Each dot is one of Grail’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Grail’s own 22.6 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Grail vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Grail's grants concentrate

Grail, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 81.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (14 grants) versus a trough of 1 in 2018. By volume, Grail sits between Freeport Minerals Corporation and Ibis Biosciences, Inc..

Grail's three-year grant acceleration

Grail, Inc. shows 36 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Freeport Minerals

55
Florida A&M Unive…

55
Foundation for Re…

55
Fujifilm Manufact…

55
Gearbox

55
George Mason Univ…

55
Hexcel Composites

55
Ibis Biosciences

55
Grail ◀

55

What this shows Grail holds 55 patents at rank #6,150, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Grail

By rank, the assignees closest to #6,150 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Grail's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Grail, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Grail ranks #106 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (60 here).

Beijing Xiaomi Pinecone Electronics Co., Ltd. 60 Gojo Industries, Inc. 60 Lexmark International, Inc. 60 NCR Atleos Corporation 60

Similar claim depth

Nearest assignees by average claims per patent (22.6 here).

AbbVie Biotechnology Ltd. 22.6 avg Magnolia Medical Technologies, Inc. 22.6 avg Seminis Vegetable Seeds, Inc. 22.6 avg Blue River Technology Inc. 22.6 avg

Grail's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Grail, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	1.8%
2019	1	1.8%
2020	3	5.5%
2021	5	9.1%
2022	9	16.4%
2023	14	25.5%
2024	13	23.6%
2025partial year	9	16.4%

Which technologies does Grail, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 45

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 35

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 15

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 11

G06N - Computing Arrangements Based ON Specific Computational Models 10

G06F - Electric Digital Data Processing 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Y - Enzymes 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G06V - Image OR Video Recognition OR Understanding 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Grail, Inc.'s patent record in context - here's where to go next.

Grail, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 81.8% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,152 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Grail, Inc. against Freeport Minerals Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.